+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Drug Eluting Balloon"

From
Infusion Balloon Catheter Market - Global Forecast 2025-2030 - Product Thumbnail Image

Infusion Balloon Catheter Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 199 Pages
  • Global
From
From
Double-wire Cutting Balloon Market - Global Forecast 2025-2030 - Product Thumbnail Image

Double-wire Cutting Balloon Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 198 Pages
  • Global
From
Drug-coated Balloon Catheter Market - Product Thumbnail Image

Drug-coated Balloon Catheter Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
From
From
UAE Cardiovascular Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Thumbnail Image

UAE Cardiovascular Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • July 2026
  • 80 Pages
  • United Arab Emirates United Arab Emirates
From
From
From
From
From
From
From
Loading Indicator

The Drug Eluting Balloon (DEB) market is a subset of the medical device industry. DEBs are used to treat peripheral artery disease (PAD) and coronary artery disease (CAD). They are designed to deliver a drug directly to the site of the blockage, allowing for improved efficacy and reduced side effects. DEBs are typically composed of a balloon catheter with a drug-eluting coating. The drug is released when the balloon is inflated, allowing for targeted delivery of the drug to the affected area. DEBs have been shown to be effective in treating PAD and CAD, and are increasingly being used in clinical practice. They offer a minimally invasive alternative to traditional treatments such as stenting and bypass surgery. Some companies in the DEB market include Medtronic, Boston Scientific, Abbott, and B. Braun. Show Less Read more